Cargando…
Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer
Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...
Autores principales: | Hidalgo-Estévez, Alicia M., Stamatakis, Konstantinos, Jiménez-Martínez, Marta, López-Pérez, Ricardo, Fresno, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201075/ https://www.ncbi.nlm.nih.gov/pubmed/32410997 http://dx.doi.org/10.3389/fphar.2020.00533 |
Ejemplares similares
-
Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy
por: Stamatakis, Konstantinos, et al.
Publicado: (2022) -
Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008) -
The Dual-Specificity Phosphatase 10 (DUSP10): Its Role in Cancer, Inflammation, and Immunity
por: Jiménez-Martínez, Marta, et al.
Publicado: (2019) -
Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
por: Fouda, Abdelrahman Y., et al.
Publicado: (2020) -
DUSP10 Is a Regulator of YAP1 Activity Promoting Cell Proliferation and Colorectal Cancer Progression
por: Jiménez-Martínez, Marta, et al.
Publicado: (2019)